Company Financials

Lotus Health Group Company Financials

Renminbi

business Lotus Health Group Company Company Profile

Main Stock Listing

SSE: 600186

Market Capitalization CN¥11.06 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 35.18
Forward PE
Price to Sales TTM CN¥3.35
Price to Book MRQ CN¥5.52
Enterprise to Revenue 2.93
Enterprise to EBITDA 17.27

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-06-30
Profit Margin 9.06%
Operating Margin 14.18%
Return on Assets TTM 8.42%
Return on Equity TTM 17.76%

Income Statement

Revenue TTM CN¥3,202,393,856
Revenue per Share TTM CN¥1.90
Quarterly Revenue Growth 22.00%
Gross Profit TTM CN¥914,578,944
EBITDA CN¥428,217,431
Net Income to Common TTM CN¥290,248,000
Diluted EPS TTM CN¥0.17
Quarterly Earnings Growth YoY 42.20%

Balance Sheet

Total Cash MRQ CN¥1,569,379,456
Total Cash per Share MRQ CN¥0.89
Total Debt MRQ CN¥
Total Debt to Equity MRQ 35.49
Current Ratio MRQ 1.84
Book Value per Share MRQ CN¥1.08

Cash Flow

Operating Cash Flow TTM CN¥312,655,712
Levered Free Cash Flow TTM CN¥-128,696,688

600186 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 1,794,002,141
Float Shares 1,342,527,389
Avg 10 Volume 81,527,346
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 26.25%
% Held by Institutions 4.32%

Stock Price Summary

Beta 0.01
Fifty Two Week Low CN¥4.23
Fifty Two Week High CN¥8.20
Fifty Two Week Change 15.05%
Day 50 MA CN¥5.72
Day 200 MA CN¥6.07

Dividends and Splits

Forward Annual Dividend Rate CN¥
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate CN¥0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date 2002-07-11
Last Split Factor
Last Split Date 2006-11-20